Skip to Main Content

958

Views

0

CrossRef citations to date

0

Altmetric

Drug Evaluation

Bemnifosbuvir (BEM, AT-527), a novel nucleotide analogue inhibitor of the hepatitis C virus NS5B polymerase

Xiao-Jian ZhouDepartments of Preclinical and Clinical Development, Atea Pharmaceuticals, Boston, MA, USACorrespondence[email protected]

https://orcid.org/0009-0009-7662-1616 View further author information

,

Steven S GoodDepartments of Preclinical and Clinical Development, Atea Pharmaceuticals, Boston, MA, USAView further author information

,

Keith PietropaoloDepartments of Preclinical and Clinical Development, Atea Pharmaceuticals, Boston, MA, USAView further author information

,

Qi HuangDepartments of Preclinical and Clinical Development, Atea Pharmaceuticals, Boston, MA, USAView further author information

,

Adel MoussaDepartments of Preclinical and Clinical Development, Atea Pharmaceuticals, Boston, MA, USAView further author information

,

Janet MJ HammondDepartments of Preclinical and Clinical Development, Atea Pharmaceuticals, Boston, MA, USAView further author information

&

Jean-Pierre SommadossiDepartments of Preclinical and Clinical Development, Atea Pharmaceuticals, Boston, MA, USAView further author information